KIR enrichment at the effector-target cell interface is more sensitive than signaling to the strength of ligand binding

被引:19
作者
Borszcz, PD
Peterson, M
Standeven, L
Kirwan, S
Sandusky, M
Shaw, A
Long, EO
Burshtyn, DN [1 ]
机构
[1] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada
[2] NIAID, Immunogenet Lab, NIH, Rockville, MD USA
[3] Univ Alberta, Fac Med & Dent, Dept Oncol, Edmonton, AB, Canada
[4] Univ Alberta, Fac Med & Dent, Cross Canc Inst, Edmonton, AB, Canada
关键词
signal transduction; NK cell; enhanced green fluorescent protein;
D O I
10.1002/eji.200323582
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Target cell lysis by natural killer cells is inhibited by killer cell immunoglobulin-like receptors (KIR) that bind major histocompatibility complex class I molecules. Many lymphocyte receptors, including KIR, become enriched at the interface with ligand-bearing cells. The contribution of the enrichment to inhibitory signaling has not been determined. We now describe a KIR variant with enhanced green fluorescent protein (EGFP) at the N terminus that can mediate inhibitory signaling, but its enrichment is markedly reduced. This receptor is only slightly weaker at inhibiting lysis than the same KIR tagged with EGFP in the cytoplasmic tail, even though the latter enriched as extensively as wild-type KIR. A slight defect was also detected in the ability of the receptor to reduce adhesion to target cells and for binding of a soluble counterpart to cell surface HLA-C. Our findings suggest that the strength of the interaction required to readily detect receptor enrichment exceeds that required for signaling.
引用
收藏
页码:1084 / 1093
页数:10
相关论文
共 40 条
  • [1] Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation
    Binstadt, BA
    Brumbaugh, KM
    Dick, CJ
    Scharenberg, AM
    Williams, BL
    Colonna, M
    Lanier, LL
    Kinet, JP
    Abraham, RT
    Leibson, PJ
    [J]. IMMUNITY, 1996, 5 (06) : 629 - 638
  • [2] Time-resolved fluorometric assay for natural killer activity using target cells labelled with a fluorescence enhancing ligand
    Blomberg, K
    Hautala, R
    Lovgren, J
    Mukkala, VM
    Lindqvist, C
    Akerman, K
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1996, 193 (02) : 199 - 206
  • [3] Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand
    Boyington, JC
    Motyka, SA
    Schuck, P
    Brooks, AG
    Sun, PD
    [J]. NATURE, 2000, 405 (6786) : 537 - 543
  • [4] Adhesion to target cells is disrupted by the killer cell inhibitory receptor
    Burshtyn, DN
    Shin, J
    Stebbins, C
    Long, EO
    [J]. CURRENT BIOLOGY, 2000, 10 (13) : 777 - 780
  • [5] Regulation through inhibitory receptors: lessons from natural killer cells
    Burshtyn, DN
    Long, EO
    [J]. TRENDS IN CELL BIOLOGY, 1997, 7 (12) : 473 - 479
  • [6] Intercellular transfer and supramolecular organization of human leukocyte antigen C at inhibitory natural killer cell immune synapses
    Carlin, LM
    Eleme, K
    McCann, FE
    Davis, DM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (10) : 1507 - 1517
  • [7] The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells
    Cohen, GB
    Gandhi, RT
    Davis, DM
    Mandelboim, O
    Chen, BK
    Strominger, JL
    Baltimore, D
    [J]. IMMUNITY, 1999, 10 (06) : 661 - 671
  • [8] The human natural killer cell immune synapse
    Davis, DM
    Chiu, I
    Fassett, M
    Cohen, GB
    Mandelboim, O
    Strominger, JL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) : 15062 - 15067
  • [9] Assembly of the immunological synapse for T cells and NK cells
    Davis, DM
    [J]. TRENDS IN IMMUNOLOGY, 2002, 23 (07) : 356 - 363
  • [10] Ig-like transcript 2 (ILT2)/leukocyte Ig-like receptor 1 (LIR1) inhibits TCR signaling and actin cytoskeleton reorganization
    Dietrich, J
    Cella, M
    Colonna, M
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (04) : 2514 - 2521